Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

Question 2

How does SKB264 compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of SKB264 and KL-A167?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer clinical trial (NCT05445908). Contact the study team or your healthcare provider for specific answers.

What this study is about